Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors

被引:132
|
作者
Xu, KL
Ma, H
McCown, TJ
Verma, IM
Kafri, T
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[4] Salk Inst, Genet Lab, La Jolla, CA 92307 USA
关键词
lentiviral vectors; transduction; expression; neurons;
D O I
10.1006/mthe.2000.0238
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To facilitate the generation of SIN lentivirus vector-producer cell lines, we have developed a novel conditional SIN (cSIN) lentivirus vector, which retains its SIN properties in normal target cells yet can be produced at high titers from tetracycline-regulated packaging cell lines. The design of the cSIN vector is based on replacing the vector U3 transcription regulatory elements with the Tet-responsive element, which allows vector production exclusively in cells expressing the synthetic Tet-regulated transactivator (tTA). In contrast minimal vector production (similar to 200 IU/ml) is obtained in target cells that do not express the tTA, even in the presence of all HIV-1 proteins. Following transduction of the Tet-regulated SODk1 lentivirus vector-packaging cell line with the cSIN vector, high titers of cSIN recombinant vector (>10(6) IU/ml) could be generated, which efficiently transduced terminally differentiated neurons in normal rat brain.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [1] A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors
    Cockrell, Adam S.
    Ma, Hong
    Fu, Kailing
    McCown, Thomas J.
    Kafri, Tal
    MOLECULAR THERAPY, 2006, 14 (02) : 276 - 284
  • [2] Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
    Hu, Peirong
    Li, Yedda
    Sands, Mark S.
    McCown, Thomas
    Kafri, Tal
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2 : 15025
  • [3] Generation of a Stable High-Titer Production Cell Line for Therapeutic AAV Vectors
    Seeber, Stefan
    Moura, Pedro A.
    Knoetgen, Hendrik
    Schaubmar, Andreas
    Schueler, Nicole
    Schneider, Alina
    Hoelper, Julia
    Faust, Nicole
    Gil-Goncalves, Ines
    Muehle, Michael
    Hussong, Michelle
    Markert, Sven
    MOLECULAR THERAPY, 2024, 32 (04) : 158 - 158
  • [4] Development of a high-titer B cell-specific self-inactivating retroviral vector
    Werner, M
    Kraunus, J
    Baum, C
    Brocker, T
    MOLECULAR THERAPY, 2003, 7 (05) : S179 - S179
  • [5] Detailed Comparison of Self-Inactivating Lentiviral Vectors Produced By Transient Transfection and Vectors Produced By the Cytegrity™ Stable Cell Line System
    Lee, Chi-Lin
    Ringpis, Gene-Errol
    Yan, Ming
    Camba-Colon, Joanna
    Zhang, Jane
    Bartlett, Jeffrey S.
    MOLECULAR THERAPY, 2015, 23 : S266 - S266
  • [6] A stable system for the high-titer production of multiply attenuated lentiviral vectors
    Klages, N
    Zufferey, R
    Trono, D
    MOLECULAR THERAPY, 2000, 2 (02) : 170 - 176
  • [7] A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors
    Knight, Sean
    Sanber, Khaled
    Stephen, Sam
    Bailey, Ranbir
    Escors, David
    Santilli, Giorgia
    Thrasher, Adrian
    Collins, Mary
    Takeuchi, Yasu
    HUMAN GENE THERAPY, 2013, 24 (05) : A23 - A23
  • [8] A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors
    Knight, Sean
    Sanber, Khaled
    Stephen, Sam
    Ferraresso, Marta
    Baley, Ranbir
    Escors, David
    Santilli, Giorgia
    Thrasher, Adrian
    Collins, Mary
    Takeuchi, Yasu
    HUMAN GENE THERAPY, 2014, 25 (11) : A101 - A102
  • [9] Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
    Cesana, Daniela
    Ranzani, Marco
    Volpin, Monica
    Bartholomae, Cynthia
    Duros, Caroline
    Artus, Alexandre
    Merella, Stefania
    Benedicenti, Fabrizio
    Sergi, Lucia Sergi
    Sanvito, Francesca
    Brombin, Chiara
    Nonis, Alessandro
    Di Serio, Clelia
    Doglioni, Claudio
    von Kalle, Christof
    Schmidt, Manfred
    Cohen-Haguenauer, Odile
    Naldini, Luigi
    Montini, Eugenio
    MOLECULAR THERAPY, 2014, 22 (04) : 774 - 785
  • [10] Generation of High-Titer Self Inactivated (SIN) γ-Retroviral Vectors in Stable Producer Cells
    Ghani, Karim
    Boivin-Welch, Michael
    Roy, Sylvie
    Caruso, Manuel
    MOLECULAR THERAPY, 2019, 27 (04) : 209 - 209